Shortly after its three-year anniversary of having the technology and under the leadership of Dr. Peter Lim, FACOG, medical director of Renown Institute for Robotic Surgery and medical director of gynecological oncology at Renown Institute for Cancer, Renown Regional Medical Center announces its designation as a GYN-Oncology Epicenter for da Vinci Robotic Surgery and the completion of its 1,000 robotic procedure.
Renown Regional is one of only 5 GYN-Onc/GYN hospitals across the United States to earn the honor of Robotic Epicenter. To be designated as an epicenter means to be a top performing center in the country for Robotic Surgery.
Additionally, Monday, April 4, Gynecologic Robotic Surgeons Dr. Martin Naughton and Dr. Elizabeth Hutson had the honors of completing Renown’s 1,000th robotic procedure. Dr. Lim completed his 384 da Vinci procedure at Renown Regional April 5. To date more than 1,003 da Vinci procedures have been done at Renown including Dr. Lim’s first on March 6, 2008.
The da Vinci Epicenter Program is designed to provide new da Vinci surgeons and their operating staff with opportunities to observe cases at distinguished training centers.
New da Vinci gynecologic surgeons and their teams visit Epicenter sites to observe cases and learn da Vinci surgical techniques and learn the operating room efficiency. Epicenter surgeons then become mentors and/or proctors for these new surgeons in their learning journey. Even after new da Vinci surgeons have successfully completed their initial case series, these mentor-trainee relationships endure through discussions at scientific conferences, the da Vinci Surgery Online Community and through advanced training.
Dr. Lim is one of the top-tier robotic surgeons in the United States in terms of experience and is popular among his colleagues for case observation. He regularly provides remote observation of live cases through da Vinci Connect, an electronic system that allows surgeons to watch da Vinci surgeries live from anywhere in the world.
“Given our continuous efforts to reach new levels of excellence and care for cancer patients, this latest designation underscores our commitment to continuous improvement and the teamwork and collaboration required to exceed national standards,” said Dr. Lim. “Surgeries where da Vinci was used have not only made a huge difference in the quality of life for my patients here locally these past three years, but I think it will also have a positive impact for others globally.”